Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06142097 · ClinicalTrials.gov registry record
Sensor Technology Assessments of Reproductive Target Study
A clinical trial, sponsored by Ouraring.
- Completed
- Registry status
- 119
- Enrollment target
NCT06142097: Completed study, sponsored by Ouraring.
NCT06142097 is a clinical trial that has completed, run by Ouraring. The registered enrollment target is 119 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06142097 has completed, sponsored by Ouraring.
- COMPLETED
- Registry status
- 119 participants
- Enrollment target
Study Summary
The objective of this study was to better understand female reproductive health in the context of using wearable technology. Participants were provided and wore an Oura Ring, tracked their menstrual cycles, provided at-home ovulation test results, and had their cycles monitored via trans-vaginal ultrasounds. The study aimed to collect data from females with regular menstrual cycles.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2022-06-15 |
| Est. Completion | 2024-09-30 |
What the finished NCT06142097 record still lists
NCT06142097 is an observational study that tracks outcomes without assigning an intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT06142097 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06142097 about?
NCT06142097 is a clinical study titled "Sensor Technology Assessments of Reproductive Target Study". The objective of this study was to better understand female reproductive health in the context of using wearable technology. Participants were provided and wore an Oura Ring, tracked their menstrual cycles, provided at-home ovulation test results, and had their cycles monitored via trans-vaginal ult...
What is the current status of trial NCT06142097?
This trial is currently completed. The enrollment target is 119 participants. The study started on 2022-06-15. Estimated completion is 2024-09-30.
Who is sponsoring clinical trial NCT06142097?
This trial is sponsored by Ouraring, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI